← All trials
NCT04391595
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Feb 28, 2022
- First posted
- May 18, 2020
- Last posted
- May 20, 2020
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Barrow Neurological InstituteLead sponsor
- University of ArizonaSponsor investigator
- Barrow Neurological InstituteCollaborator
- Ivy Brain Tumor CenterCollaborator
- Ivy Brain Tumor CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.